ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 906,58
0,00%
Dow Jones
44 713,58
0,65%
DAX
21 282,18
-0,48%
Brent Oil
76,585
0,41%
Bitcoin
102 849,75
0,77%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Canadá
  5. TSXV
  6. Essa Pharma Inc (EPI)

  7. Essa Pharma Inc (EPI) Actualités

EPI

Essa Pharma (EPI)

Essa Pharma Inc
De:
Trier par:
 Showing the most relevant articles for your search:TSXV:EPI
DateHeureSourceTitreSymboleSociété
26/02/202100h33PR Newswire (Canada)ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of ShareholdersTSXV:EPIEssa Pharma Inc
13/01/202113h00PR Newswire (Canada)ESSA Pharma Announces Clinical Collaboration with Janssen to Evaluate EPI-7386 Combination for Patients with Metastatic Castr...TSXV:EPIEssa Pharma Inc
15/12/202023h01PR Newswire (Canada)ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 20...TSXV:EPIEssa Pharma Inc
25/11/202013h00PR Newswire (Canada)ESSA Pharma to Participate at Evercore ISI 3rd Annual HealthCONx ConferenceTSXV:EPIEssa Pharma Inc
26/10/202022h01PR Newswire (Canada)ESSA Pharma Inc. Announces Delisting from the TSX-VTSXV:EPIEssa Pharma Inc
25/10/202001h18PR Newswire (Canada)ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 32nd EORTC-NCI-AACR SymposiumTSXV:EPIEssa Pharma Inc
19/10/202013h00PR Newswire (Canada)ESSA Pharma Announces Multiple Abstracts Accepted for Presentation at Upcoming Medical and Scientific SymposiaTSXV:EPIEssa Pharma Inc
21/09/202013h00PR Newswire (Canada)ESSA Pharma to Participate in Oppenheimer Fall Healthcare Life Science & MedTech SummitTSXV:EPIEssa Pharma Inc
17/09/202023h05PR Newswire (Canada)ESSA Pharma Announces the Presentation of Additional Preclinical Data for EPI-7386 at the ESMO Virtual Congress 2020TSXV:EPIEssa Pharma Inc
14/09/202013h00PR Newswire (Canada)ESSA Pharma Announces Fast Track Designation Granted by the FDA to EPI-7386 for the Treatment of Metastatic Castration-Resist...TSXV:EPIEssa Pharma Inc
10/09/202013h00PR Newswire (Canada)ESSA Pharma to Participate in Multiple Upcoming Investor ConferencesTSXV:EPIEssa Pharma Inc
07/08/202002h00PR Newswire (Canada)ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2020TSXV:EPIEssa Pharma Inc
31/07/202016h16PR Newswire (Canada)ESSA Pharma Completes Public Offering for Aggregate Gross Proceeds of US$48,990,000TSXV:EPIEssa Pharma Inc
29/07/202015h07PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - EPITSXV:EPIEssa Pharma Inc
29/07/202015h05PR Newswire (Canada)IIROC Trading Resumption - EPITSXV:EPIEssa Pharma Inc
29/07/202003h18PR Newswire (Canada)ESSA Pharma Announces Pricing of Public Offering of Common SharesTSXV:EPIEssa Pharma Inc
28/07/202022h03PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - EPITSXV:EPIEssa Pharma Inc
28/07/202022h01PR Newswire (Canada)ESSA Pharma Announces Proposed Public Offering of Common SharesTSXV:EPIEssa Pharma Inc
28/07/202022h01PR Newswire (Canada)IIROC Trading Halt - EPITSXV:EPIEssa Pharma Inc
15/07/202013h00PR Newswire (Canada)ESSA Pharma Announces First Patient Dosed in a Phase 1 Clinical Trial of EPI-7386 for Metastatic Castration-Resistant Prostra...TSXV:EPIEssa Pharma Inc
22/06/202013h30PR Newswire (Canada)ESSA Pharma Presents Therapeutic Potential of EPI-7386 at the 2020 American Association for Cancer Research Virtual Annual Me...TSXV:EPIEssa Pharma Inc
27/05/202013h00PR Newswire (Canada)ESSA Pharma to Present at Jefferies Virtual Healthcare ConferenceTSXV:EPIEssa Pharma Inc
15/05/202013h30PR Newswire (Canada)ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 2020 Virtual American Urological Association (AUA) Annual MeetingTSXV:EPIEssa Pharma Inc
07/05/202023h05PR Newswire (Canada)ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2020TSXV:EPIEssa Pharma Inc
30/04/202023h45PR Newswire (Canada)ESSA Pharma Announces FDA Allowance of the Clinical Investigation of EPI-7386 in Prostate CancerTSXV:EPIEssa Pharma Inc
14/04/202000h08PR Newswire (Canada)ESSA Pharma Enters into At-The-Market Equity Offering Sales AgreementTSXV:EPIEssa Pharma Inc
31/03/202013h00PR Newswire (Canada)ESSA Pharma Submits IND for EPI-7386 for Prostate Cancer and Provides Business UpdateTSXV:EPIEssa Pharma Inc
13/02/202023h48PR Newswire (Canada)ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2019TSXV:EPIEssa Pharma Inc
30/10/201911h00PR Newswire (Canada)ESSA Pharma Grants Stock OptionsTSXV:EPIEssa Pharma Inc
28/10/201912h30PR Newswire (Canada)ESSA Pharma Presents Data on EPI-7386 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeu...TSXV:EPIEssa Pharma Inc
 Showing the most relevant articles for your search:TSXV:EPI

Dernières Valeurs Consultées

NYSE
NKE
Nike
EU
CS
Axa
NYSE
MRK
Merck
COIN
ETHUSD
Ethereum
NASDAQ
GOOGL
Alphabet
EU
BNP
BNP Paribas
EU
ACA
Credit Agricole
EU
CAP
Capgemini
EU
BEL20
Bel 20
COIN
ADAUSD
Cardano
EU
AF
Air FranceKLM
COIN
BTCUSD
Bitcoin
EU
MC
Lvmh Moet Hennessy Louis...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés